News MedicalThe Coffee Advice Given to Atrial Fibrillation Patients May Deserve a Rethink

⚠️ Small Study / Early Comparative Evidence

Coffee avoidance remains common advice for patients with atrial fibrillation despite limited randomized evidence supporting caffeine restriction. In DECAF, daily caffeinated coffee consumption was associated with a lower risk of clinically detected recurrent AF or atrial flutter after cardioversion.

Clinical Considerations

• 200 patients undergoing cardioversion were randomized to daily caffeinated coffee consumption or caffeine abstinence.
• Coffee consumption was associated with a 39% lower hazard of clinically detected AF or flutter recurrence.
• No meaningful differences in adverse events were reported between intervention and abstinence groups.
• Proposed biological mechanisms include adenosine receptor blockade, anti-inflammatory effects, and broader cardiometabolic influences.

Practice Applications

• Consider existing evidence before routinely advising universal caffeine avoidance in AF.
• Recognize that observational and randomized findings generally have not shown AF worsening.
• Interpret the DECAF findings as early randomized evidence rather than definitive practice-changing data.
• Monitor for future studies evaluating dose-response effects and longer-term outcomes.